详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: Executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis (Open Access)

78| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China [2]Department of Neurology and Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China [3]Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [4]Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [5]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [6]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [7]Department of Neurology,Huashan Hospital, Fudan University, Shanghai, China [8]Department of Neurology and Stroke Center, the First Affiliated Hospital, Jinan University, Guangzhou, China [9]Department of Neurology, The Southwest Hospital, the First Affiliated Hospital of Third Military Medical University, Chongqing, China [10]Shanghai Institute of Cardiovascular Diseases,Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China [11]Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China [12]Department of Neurology, West China Hospital, Sichuan University, Chengdu, China [13]Department of Neurology, Union Hospital,Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China [14]Department of Cardiology, Peking University First Hospital, Beijing, China [15]Department of Endocrinology and Metabolism, Peking University People's Hospital, Medicine at Peking University,Beijing, China [16]Department of Neurosurgery, Xuanwu Hospital, Capital University of Medicine,Beijing,China [17]Zhujiang Hospital of Southern Medical University, Guangzhou, China [18]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [19]Department of Neurology, 1st Affiliated Hospital of Zhejiang University, Hangzhou, China [20]Department of Interventional Neuroradiology,Beijing Tiantan Hospital, Capital Medical University, Beijing, China [21]Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China [22]Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China [23]Department of Pharmacology, the Second Military Medical University(SMMU), Shanghai, China [24]Department of Neurology, Xiangya Hospital, Central South University, Changsha, China [25]Beijing Tiantan Hospital, Capital Medical University, Beijing, China [26]Department of Neurology and Institute of Neurology, First Affiliated Hospital of Fujian Medical University, Fuzhou, China [27]Department of Neurosurgery,Beijing Tiantan Hospital, Capital Medical University, Beijing,China [28]Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [29]Department of Neurology,Zhongshan Hospital, Fudan University, Shanghai, China [30]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University,Beijing, China [31]Qinghai Province People's Hospital, Xining, China [32]Chongqing Medical University (CQMU), Chongqing, China [33]Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [34]Department of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China [35]Department of Neurology, the First Hospital of Jilin University,Changchun, China [36]Department of Neurology and Stroke Center, the First Affiliated Hospital of Sun Yat-Sen University,Guangdong, China [37]The First affiliated Hospital of China Medical University, Shenyang, China [38]Capital Medical University School of Rehabilitation Medicine, China Rehabilitation Research Center, Beijing, China [39]Zhuo Zhang Department of Neurology, Xijing Hospital, The 4th Military Medical University, Xi’an, China [40]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

出处：

DOI：

ISSN：

关键词： brain MRI vein

摘要：

Aim: Cerebral venous sinus thrombosis (CVST) is a less common cerebrovascular disease that predominantly affects young patients. The incidence of CVST is 2-5/10 000 000/year, accounting for 0.5%-1% of all stroke. To reduce mortality and morbidity associated with CVST, Chinese Stroke Association commissioned the authors to write the current guideline on the management of CVST. Methods: PubMed (MEDLINE), CNKI and Wanfang database were searched for studies related to CVST from 1 January 1990 to 31 July 2019. Data were synthesised by evidence tables. Each recommendation was fully discussed by the writing group members and reviewed by Chinese Stroke Association Stroke Fellow Committees. Levels of evidence grading algorithm of Chinese Stroke Association was used to grade each recommendation. Results: This guideline mainly focuses on the diagnostic evaluation, therapeutic strategies and secondary prevention of CVST. CT/CTV and MRI/MRV are recommended in the initial imaging evaluation of patients with suspected CVST. Anticoagulation therapy with low-molecular weight heparin should be initiated in patients with CVST immediately. After the acute stage, warfarin is recommended for 3-6 months to prevent the recurrence of CVST and other venous thromboembolic events. Conclusions: The guideline summarises the current evidence regarding the management of CVST, and provides references for diagnosis, treatment and secondary prevention of CVST in China. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2019]版：

无

最新[2025]版：

大类 | 2 区医学

小类 | 2 区临床神经病学

JCR分区：

出版当年[2018]版：

无

最新[2024]版：

Q1 CLINICAL NEUROLOGY

影响因子： 4.9 最新[2024版] 5.9 最新五年平均 0 出版当年[2018版] 0 出版当年五年平均 0 出版前一年[2017版] 4.765 出版后一年[2019版]

第一作者：

第一作者机构： [1]Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: Executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis (Open Access)

文献详情

相关文献